BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. Announces Final Results Of Quarterly Tender Offer For Up To 2.5% Of The Fund’s Issued And Outstanding Shares Of Common Stock

BNY Mellon Alcentra Global Multi-Strategy Credit Fund, Inc. (the “Fund”) today announced the final results of its quarterly tender offer (the “Tender Offer”) for up to 2.5% of the Fund’s issued and outstanding shares of common stock (the “Shares”).

The Tender Offer, which expired at 5:00 p.m. Eastern time on November 14, 2023, was oversubscribed.

Therefore, in accordance with the terms and conditions of the Tender Offer, the Fund will purchase Shares from all tendering shareholders on a pro rata basis, after disregarding fractions, based on the number of Shares properly tendered (“Pro-Ration Factor”). The final results of the Tender Offer are provided in the table below.

If you have questions about the Tender Offer and hold Shares through a broker or other nominee holder, you can call your broker or other nominee holder directly. You may also call Georgeson LLC (“Georgeson”), the Fund’s Tender Offer information agent, toll free at (877) 278-9670, with any questions.

The terms and conditions of the Tender Offer were set forth in the Fund’s Offer to Purchase, the related Letter of Transmittal and other related documents. The Fund filed with the Securities and Exchange Commission (the “SEC”) a tender offer statement on Schedule TO and related exhibits, including an Offer to Purchase, a related Letter of Transmittal and other related documents (the “Offer Documents”). Shareholders may obtain copies of the Offer Documents, without charge, by contacting Georgeson toll free at (877) 278-9670. Shareholders can also obtain the Offer Documents free of charge on the SEC’s website at www.sec.gov.

The Fund also announced the tentative dates for the Fund’s tender offers in 2024, subject to approval of the Fund’s Board of Directors (the “Board”). The tentative dates are as follows:

These tentative dates are still subject to Board approval and should not be relied on. There can be no assurance that the Board will proceed with any tender offer and the terms of any future tender offer, including the applicable dates associated with those tender offers, are subject to change.

The Fund intends, but is not obligated, to conduct quarterly tender offers for up to 2.5% of its shares of common stock (“Shares”) then outstanding in the sole discretion of the Board. In determining whether the Fund should conduct a tender offer, the Board will consider the recommendation of BNY Mellon Investment Adviser, Inc. (“BNYM Investment Adviser”), the Fund’s investment manager, and Alcentra NY LLC (“Alcentra”), the Fund’s sub-investment adviser, as well as a variety of operational, business and economic factors. In any given quarter, BNYM Investment Adviser and Alcentra may or may not recommend to the Board that the Fund conduct a tender offer, and even if BNYM Investment Adviser and Alcentra do recommend to the Board that the Fund conduct a tender offer, the Board may not approve such recommendation.

While the Fund intends to conduct quarterly tender offers as described in the Fund’s initial public offering prospectus, the Fund is not required to do so and may amend, suspend or terminate any such tender offer program at any time. Holders of Shares (“Shareholders”) have no right to require the Fund to redeem their Shares. Quarterly tender offers may be delayed or discontinued at any time. It is also possible that if a tender offer is conducted, it may be oversubscribed, with the result that Shareholders may only be able to have a portion of their Shares repurchased. There is no assurance that a Shareholder will be able to tender their Shares when or in the amount that they desire.